InsidersTradesSigma
Total declarations
Company
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Samsara BioCapital, L.P.. Insider active across 1 companies, notably Graphite Bio, Inc.. Aggregated, 15 disclosures have been recorded. Total volume traded: €9.3m. The latest transaction was filed on 11 April 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations15 total
€278,60874,464 shares@ €3.74153.0% of flow
Common Stock
SEC:0001209191-22-024364:0·
Ideal exit: 6 Jan 2023 (T+270)
€794,608100,000 shares@ €7.94618.5% of flow
Common Stock
SEC:0001209191-22-004735:0·
Ideal exit: 18 Oct 2022 (T+270)
€794,608100,000 shares@ €7.946117.6% of flow
Common Stock
SEC:0001209191-22-004735·
Ideal exit: 18 Oct 2022 (T+270)
€445,01054,565 shares@ €8.15569.9% of flow
Common Stock
SEC:0001209191-22-004346·
Ideal exit: 16 Oct 2022 (T+270)
€445,01054,565 shares@ €8.15564.8% of flow
Common Stock
SEC:0001209191-22-004346:0·
Ideal exit: 16 Oct 2022 (T+270)
€202,04922,329 shares@ €9.04874.5% of flow
Common Stock
SEC:0001209191-21-070500·
Ideal exit: 11 Sept 2022 (T+270)
€202,04922,329 shares@ €9.04872.2% of flow
Common Stock
SEC:0001209191-21-070500:0·
Ideal exit: 11 Sept 2022 (T+270)
€2m201,685 shares@ €9.001640.3% of flow
Common Stock
SEC:0001209191-21-066742·
Ideal exit: 19 Aug 2022 (T+270)
€2m201,685 shares@ €9.001619.5% of flow
Common Stock
SEC:0001209191-21-066742:0·
Ideal exit: 19 Aug 2022 (T+270)
€517,42245,400 shares@ €11.39711.5% of flow
Common Stock
SEC:0001209191-21-060627·
Ideal exit: 10 Jul 2022 (T+270)
€517,42245,400 shares@ €11.3975.6% of flow
Common Stock
SEC:0001209191-21-060627:0·
Ideal exit: 10 Jul 2022 (T+270)
€735,76261,475 shares@ €11.968516.3% of flow
Common Stock
SEC:0001209191-21-060060·
Ideal exit: 3 Jul 2022 (T+270)
€735,76261,475 shares@ €11.96857.9% of flow
Common Stock
SEC:0001209191-21-060060:0·
Ideal exit: 3 Jul 2022 (T+270)
6,167,763 shares
Common Stock
SEC:0001209191-21-044507·
6,167,763 shares
Common Stock
SEC:0001209191-21-044507:0·
15 of 15 declarations
About Samsara BioCapital, L.P.
Samsara BioCapital, L.P. is an investor in Graphite Bio, Inc. and plays a key role in the company's funding.
